Association between Nafamostat Mesylate and In-Hospital Mortality in Patients with Coronavirus Disease 2019: A Multicenter Observational Study

Nafamostat mesylate may be effective against coronavirus disease 2019 (COVID-19). However, it is not known whether its use is associated with reduced in-hospital mortality in clinical practice. We conducted a retrospective observational study to evaluate the effect of nafamostat mesylate in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Inokuchi, Ryota, Kuno, Toshiki, Komiyama, Jun, Uda, Kazuaki, Miyamoto, Yoshihisa, Taniguchi, Yuta, Abe, Toshikazu, Ishimaru, Miho, Adomi, Motohiko, Tamiya, Nanako, Iwagami, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745709/
https://www.ncbi.nlm.nih.gov/pubmed/35011857
http://dx.doi.org/10.3390/jcm11010116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745709/
https://www.ncbi.nlm.nih.gov/pubmed/35011857
http://dx.doi.org/10.3390/jcm11010116

Ejemplares similares